Ann: ResAppDx to be Formally Evaluated by Doctors Without Borders, page-19

I cannot speak for short term investors or traders. But as a long term investor, this is very good news. This is the kind of foundation partnership that will put RAP in good stead for many years to come. I hear some say there is no money. WHAT is money? To me, the DATA collected by MSF for RAP is worth more than money. After all, the only thing preventing others from replicating RAP is the data that RAP has. It is the data that allows RAP to produce all the information required to process the outcome of the 'cough'. Without it, RAP is nothing. And the more data it has, the more accurate the learning app will become. So I ask again, how much is the DATA that MSF is going to collect for RAP worth? Or to put it another way. How much would it cost RAP to put out 30,000 doctors into the field to collect those data? That is MONEY without having the responsibility that MSF has towards its doctors.